4 acid at sn2 position, indicating that chlamydiae uptake and modify host glycerophospholipids. Obviously, a pre-requirement of such modification is liberation of the free fatty acid at the sn2 position of the host phospholipids, which is achieved through hydrolysis as catalyzed by phospholipase A2 (PLA2). However, no phospholipase A2 homologues have been identified in chlamydial genomes (23, 25, 26) . Therefore, we propose that chlamydiae must rely on host phospholipase A2.
Numerous types of eukaryotic PLA2s have been identified (34, 35) , including both Ca2+-dependent cytosolic PLA2 (cPLA2) and Ca2+ -independent PLA2 (iPLA2). The cPLA2 activity can be inhibited by either chemical inhibitors (e.g. AACOCF3) or Ca++ depletion. The activation of cPLA2 requires phosphorylation at multiple sites, which can be carried out by various upstream kinases including the MAP kinase ERK1/2 (36) (37) (38) ). Here we demonstrate that both MAP kinase ERK1/2 and cPLA2 are activated during chlamydial intracellular replication and inhibition of either leads to suppression of chlamydial uptake of host glycerophospholipids and chlamydial replication.
Materials and Methods

Cell culture and chlamydial infection
HeLa, 293T (ATCC, Manassas, VA 20108) and MS-74 (endometrial epithelial primary cells kindly provided by Dr. John Alderete from the University of Texas Health Science Center at San Antonio) were maintained in DMEM (cat#11995-065, GIBCO BRL, Rockville, MD) with 10% fetal calf serum (FCS; GIBCO BRL) at 37 0 C in an incubator supplied with 5% CO2. The C. trachomatis serovar L2 (434/Bu) organisms obtained from Dr. C. Kuo at the University of Washington (Seattle) were grown, purified and titrated as previously described (39) . Aliquots of chlamydial organisms were stored at -80 o C. The to transfect 293T cells (ATCC) 24 hours prior to chlamydial infection as described previously (40, 41) .
The epidermal growth factor (EGF, Sigma) was used at 100 ng/ml for 5 min as positive control for activation of MAP kinase signaling pathway. At the end of the incubation period, cultures were processed or harvested for analysis as described below. For Western blot analysis, the cells were harvested with a SDS sample buffer {2% SDS (Sigma), 50 mM DTT (Sigma) in 62.5mM Tris-HCl (Sigma) at pH 6.8}.
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(Upstate, Lake Placid, NY), chlamydial major outer membrane protein (MOMP; clone MC22, unpublished data) and a FLAG tag (M2, Sigma) and rabbit IgGs to phosphorylated cPLA2 (p-cPLA2), pERK1/2, pELK-1, MEK1/2, pMEK1/2 (all from Cell Signaling), total Raf-1, Tyr340 phosphorylated Raf-1 (both from Santa Scruz Biotechnology). Primary antibody binding was probed with corresponding secondary antibodies conjugated with horseradish peroxidase (Jackson ImmunoResearch Laboratories, Inc. West Grove, PA), followed by standard ECL (Amersham Biosciences Corp). The kinase activity of ERK1/2 in chlamydia-infected cells was measured with a recombinant ELK-1 as substrate in a cell-free assay system following the instruction described in the manufacture's manual (Cell Signaling). The level of GTP-bound Ras in chlamydia-infected cells was detected using immunoprecipitation with glutathioneagarose beads bound with Ras binding domain of Raf-1 (RBD)-GST (glutathione-S-transferase) fusion protein following the manufacture's instruction (Upstate).
Immunofluorescence assay
For immunofluorescence staining (29) , cells grown on coverslips were fixed with 2% paraformaldehyde in PBS (phosphate-buffered saline solution) for 30 min at room temperature, followed by permeabilization with 1% saponin for an additional 30 min. After washing and blocking, a rabbit antiserum recognizing chlamydial organisms (R1L2; unpublished data) or an anti-chlamydial LPS mAb (clone# MB5H9; unpublished data) was used to detect chlamydial inclusions. For localizing pERK1/2 or p-cPLA2, the cell samples were co-stained with a mouse mAb to pERK1/2 or a rabbit antiserum to pcPLA2 (Cell Signaling). After washing away the unbound first antibodies, the appropriate secondary antibody conjugate combinations {consisting of a goat anti-rabbit IgG-conjugated with Cy2 (green), goat anti-mouse IgG-conjugated with Cy3 (red; Jackson ImmunoResearch Laboratories, Inc) and Hoechst dye (blue for DNA, Sigma, St. Louis, MO)} were used to visualize the first antibody staining. The triply stained cell samples were used for image acquisition with an Olympus AX-70 fluorescence microscope.
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The images were acquired single color at a time using a Hamamatsu digital camera and superimposed with the software SimplePCI. For titrating IFUs, the chlamydia-infected cultures were singly stained for chlamydial inclusion as described above. cell harvesting, and quantitation of radiolabel incorporated into DNA were conducted as previously described (21) . Radiolabel was added at 20 h post-infection, when C. trachomatis DNA synthesis is at a maximum and cultures were harvested 3 h later. All results were normalized to 10 6 cells. 
Extraction and Purification of Lipids
Results
cPLA2 is activated during chlamydial infection and required for chlamydial uptake of host glycerophospholipids
To evaluate if host cPLA2 is activated following chlamydial infection, we monitored the extent of phosphorylation of cPLA2 during the entire course of chlamydial infection (Fig. 1A ). There was a basal level of cPLA2 phosphorylation in HeLa cells in the absence of chlamydial infection (0h, top panel).
However, the level of phosphorylated cPLA2 was significantly higher in HeLa cells infected with chlamydiae for12 hours and continued to increase as infection progressed. As sample loading control, the total amount of cPLA2 was monitored and showed no significant difference between cell samples ( Furthermore, AACOCF3 but not BEL (an iPLA2-specific inhibitor) significantly reduced chlamydial growth as assessed by the incorporation of radiolabeled adenine into parasite DNA ( Fig. 1C ) and production of infectious elementary bodies (EBs) as measured by quantitating the number of infectious particles recovered (Fig. 1D ). Since the activity of cPLA2 requires Ca++, we next determined the effects 9 of Ca++ depletion on chlamydial uptake of host glycerophospholipids. As shown in Fig. 1E , the cellpermeable calcium chelator BAPTA/AM was as efficient as AACOCF3 (see Fig. 1B ) in reducing the amount of host lipids trafficked to chlamydiae. The intracellular calcium depletion also inhibited chlamydial growth (Fig. 1F ). In contrast, chelating extracellular Ca++ with BAPTA had no obvious effect on chlamydial growth (Fig. 1F , open circles). Taken together, these observations demonstrate that chlamydial infection is accompanied with activation of cPLA2 and the activated cPLA2 is required for chlamydial salvage of host glycerophospholipids. We next investigated the molecular mechanism responsible for cPLA2 activation during chlamydial infection.
Activation of MAP kinase signaling pathway during chlamydial infection is required for cPLA2 phosphorylation and chlamydial uptake of host glycerophospholipids
Since one of the upstream kinases for activating cPLA2 is Extracellular Signal-Regulated Kinase (ERK), we tested whether ERK1/2 is also activated during chlamydial infection. As shown in Fig. 2A , although the control HeLa cells showed a minimal level of ERK1/2 phosphorylation, the cells infected with chlamydiae for 12 hours displayed a dramatically higher level of phosphorylated ERK1/2 and the level of ERK1/2 phosphorylation continued to increase as infection progressed (top panel). The phosphorylated ERK1/2 harvested from the chlamydia-infected samples was measured for kinase activity using ELK-1 fusion protein as substrate ( Fig. 2A, bottom panel) . The kinase activity of ERK1/2 correlated well with the level of ERK1/2 phosphorylation. The total ERK1/2 protein was measured in parallel and no significant difference in the levels of total ERK1/2 protein was noted between samples ( Fig. 2A, 
Activation of ERK1/2 and cPLA2 is dependent on chlamydial growth
So far we have demonstrated that the MEK1/2-ERK1/2 signaling pathway is required for cPLA2 activation in chlamydia-infected cells. However, it is not known how MEK1/2-ERK1/2 itself is activated during chlamydial infection. We found that activation of both ERK1/2 and cPLA2 correlated well with chlamydial infection dose and as infection doses increased, higher levels of ERK1/2 and cPLA2 phosphorylation were detected (Fig. 3A) , which suggests that chlamydial replication is involved in activating these host signaling molecules. To evaluate whether chlamydial protein synthesis is required for the ERK1/2 and cPLA2 activation during chlamydial infection, we assessed the effects of antibiotics that selectively block either chlamydial protein synthesis or chlamydial particle assembly on host ERK1/2 and cPLA2 activation (Fig. 3B) . Both rifampin (able to inhibit prokaryotic transcription) and chlororamphenicol (able to prevent prokaryotic translation) successfully blocked chlamydial protein synthesis (bottom panel). Consequently, the levels of both phosphorylated ERK1/2 and cPLA2 were 12 dramatically suppressed in chlamydia-infected cultures treated with either rifampin or chlororamphenicol (top and third panel). However, penicillin G, known to interfere with chlamydial reticulate body (RB)
replication and RB to EB differentiation without affecting protein synthesis, failed to block chlamydiainduced ERK1/2 and cPLA2 phosphorylation. These observations together have demonstrated that chlamydial protein synthesis is required for chlamydial activation of ERK1/2-cPLA2 signaling pathway during chlamydial intravacuolar replication. Although ERK1/2 was also transiently activated as early as 10 minutes after infection (Data not shown; (46) , this immediate response is independent of chlamydial biosynthesis (Data not shown).
We used immunofluorescence microscopy to localize the phosphorylated ERK1/2 ( 
Discussion
During chlamydial intravacuolar replication, the readily available nutrients and energy in host cell cytosols are transported into the chlamydial vacuoles (15, 20, 33, (47) (48) (49) . We have previously presented evidence that chlamydiae can salvage glycerophospholipids from host cells (32,33). In addition, it is known that sphingomyelin (SM; (16, 47) and cholesterol (15) are also trafficked to chlamydiae from the host. Unlike SM and cholesterol, which are trafficked unmodified, host cell glycerophospholipids are modified such that a host-synthesized straight-chain fatty acid is replaced with a chlamydia-synthesized by guest on January 9, 2018 http://www.jbc.org/ Downloaded from 13 branched chain fatty acid. Most of the branched chain fatty acid is located in the sn-2 position of the hostderived glycerophospholipid. Results presented in this study conclusively demonstrate that activation of host cell cPLA2 is a prerequisite for glycerophospholipid trafficking from the host to chlamydiae and blocking the glycerophospholipid trafficking can severely impair chlamydial growth. Thus, despite the fact that chlamydiae contain the genes encoding all enzymes required for de novo synthesis of PG, PS and PE (23), importing glycerophospholipids from the host cell is still indispensable for normal growth and development. The evolution of this sort of intimate metabolic association between chlamydiae and its host is likely a major contributing factor to chlamydiae being obligate intracellular parasites. This intimate metabolic association may have the following consequences. First, being able to obtain glycerophospholipids from the host cell provides major energy savings for chlamydiae. Chlamydiae have an unusually high demand for lipids since, in addition to an inner and outer membrane typical of Gramnegative bacteria, they possess a unique inclusion membrane that is indispensable for chlamydial survival.
Second, dependence on host cells for phospholipids may also serve as a sensoring mechanism for chlamydiae to monitor the host cytoplasmic environment. Chlamydiae may be able to adjust their phospholipid metabolism in response to the cytosolic environment of the host cell as in the case of chlamydial persistence induced by tryptophan or iron depletion (50-52). It will be interesting to test whether inhibition of host cPLA2 activity can indeed trigger the development of persistent chlamydial forms. Third, it may be advantageous for chlamydiae to incorporate host lipids into their inclusion membrane as this could give the membrane a "host-like" appearance, which may help prevent the chlamydial vacuole from being detected as foreign by host cell defense mechanisms. Finally, chlamydial activation of cPLA2 may also contribute to chlamydia-induced local inflammation since arachidonic acid release, an inevitable consequence of cPLA2 activity, is greatly increased in chlamydia-infected cells (data not shown). Determination of cPLA2 involvement in inflammation at the site of chlamydial infection, although beyond the scope of this study, is underway. The current study has presented compelling evidence that activation of host MAP kinase ERK1/2-cPLA2 signaling pathway is required for chlamydial uptake of host glycerophospholipids. First, both the RasRaf-MEK1/2-ERK1/2 MAP kinase pathway and cPLA2 are activated during chlamydial infection.
Second, inhibition of cPLA2 activity blocked chlamydial uptake of host lipids and impaired chlamydial growth. Third, both the Raf-1-specific inhibitor GW5074 and the MEK1/2-specific inhibitor U0126
prevented activation of ERK1/2 and cPLA2. Fourth, inhibition with U0126 suppressed chlamydial uptake of host glycerophospholipids and reduced chlamydial growth. Finally, a dominant negative ERK2
construct blocked phosphorylation of cPLA2 in chlamydia-infected cells, which independently confirmed the indispensable role of ERK1/2 in chlamydial activation of cPLA2.
In mammals, the ERK1/2-mediated MAP kinase signaling pathway regulates many important cellular functions including cell survival and proliferation (e.g. through phosphorylation of transcription factors by nuclear ERK1/2; ref: (53) (54) (55) (56) . The cytosolic phospholipase A2 is one of the many potential cytosolic substrates of ERK1/2 (37, 53) . Activating host ERK1/2 may not only facilitate chlamydial uptake of host phospholipids but also allow chlamydiae to gain advantages in evading host defense. For example, host cell apoptosis plays important role in both innate and adaptive immunity against intracellular infections (57, 58) . However, chlamydiae possess a strong antiapoptotic activity (11) , which is consistent with the ability of ERK to promote cell proliferation (53, 54) . Although we have not determined precisely how much the chlamydia-activated ERK contributes to chlamydial antiapoptotic activity, it is certain that maintaining the viability of chlamydia-infected cells during chlamydial intracellular replication will benefit chlamydial survival in the infected hosts. Being consistent with ERK activation, chlamydiainfected cells can up-regulate expression of genes for promoting cell survival (59) and also secrete a large amount of cytokines (60) . Interestingly, many other intracellular pathogens have also acquired the ability to activate host ERK1/2-mediated signaling pathways for benefiting microbial survival. For example, inhibition of ERK signaling pathway can significantly reduce Coxsackievirus B3 replication (61) and the Raf/MEK/ERK signaling cascade is required for transportation of influenza viral ribonucleoprotein complexes from host cell nuclei into cytosol for viral particle assembly (62) .
At the present time, we are unsure of how chlamydiae activate the MAP kinase-cPLA2 signaling Regardless of the precise intracellular molecules with which chlamydiae interact, the fact that chlamydial growth and protein synthesis are required for the chlamydia-induced phosphorylation of ERK1/2 strongly suggests that chlamydiae secrete factors into host cell cytosols for activating the host MEK1/2-ERK1/2-cPLA2 signaling pathway. We are actively searching for the potential chlamydial factors. (4 th ), total cPLA2 (5 th ) and phosphorylated cPLA2 (bottom). "ns" stands for non-specific binding. In host cell cytoplasm, MAP kinase pathway is activated by chlamydiae either at the step of small GTPase Ras or c-Raf-1 kinase, which finally leads to phosphorylation of cPLA2. The activated cPLA2
Figure legends
can hydrolyze host phospholipids into lysophospholipids by removing the fatty acid at the sn2 position.
The lysophospholipids are then taken up by chlamydiae. In a chlamydial organism inside the chlamydial inclusion, chlamydiae modify the host lysophospholipids by adding a chlamydia-synthesized fatty acid with branched chain to the sn2 position. Since only the prokaryotic chlamydia organisms can use the side chain of isoleucine to make the branched chain fatty acid, lipid-associated radioactivity isolated from chlamydia-infected cultures after H 3 -isoleucine (ILE) pulsing can be used to measure the level of chlamydial lipid biosynthesis and chlamydial uptake of host phospholipids. GLC=glucose;
GLC6P=glucose-6-phosphate. Arrows stand for positive signaling/biochemical reactions and T shape stands for inhibitory reactions. All inhibitors are listed in italic and described in the materials and methods section.
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